A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2001
12/12/2001	EP1077688B1 Transdermal therapeutic system containing pergolide
12/12/2001	EP1032379B1 Composition with azelaic acid
12/12/2001	EP0983266B1 novel tetrahydroisoquinolin thiophenecarboximidamides
12/12/2001	EP0981340B1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
12/12/2001	EP0971708B1 Nimesulide gel systems for topical use
12/12/2001	EP0966431B1 Salicylic acid-sphingoid base derivatives and uses thereof
12/12/2001	EP0941064A4 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0888285B1 Novel bridged cyclic amino acids as pharmaceutical agents
12/12/2001	EP0874854B1 Cephalosporin antibiotics
12/12/2001	EP0869941B1 Modified polyunsaturated fatty acids
12/12/2001	EP0861248B1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
12/12/2001	EP0854708B1 Lipid alcohols as new immunosuppressive and antiviral drugs
12/12/2001	EP0836480B1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/12/2001	EP0828502B1 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
12/12/2001	EP0788356B1 Method and compositions for inhibiting protein kinases
12/12/2001	EP0785788B1 Use of cck-b receptor antagonists for the treatment of sleep disorders
12/12/2001	EP0785787B1 Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus
12/12/2001	EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
12/12/2001	EP0772597B1 3,4-substituted pyrazoles for the treatment of inflammation
12/12/2001	EP0766570B1 Methods for treating respiratory disease
12/12/2001	EP0760665B1 Compositions containing 5htia and 5htid antagonists
12/12/2001	EP0751764B1 Retinal-containing composition
12/12/2001	EP0748319B1 Process for making an epoxide
12/12/2001	EP0732923B1 Pharmaceutical compositions containing HIV protease inhibitors
12/12/2001	EP0728002B1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
12/12/2001	EP0723540B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
12/12/2001	EP0723539B1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
12/12/2001	EP0723538B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
12/12/2001	EP0716602B1 The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
12/12/2001	EP0688213B1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity
12/12/2001	EP0663912B1 Heterocyclic ether compounds that enhance cognitive function
12/12/2001	EP0662946B2 Unsaturated aliphatic dicarboxylic acids
12/12/2001	EP0662075B1 Prostaglandin analog for treating osteoporosis
12/12/2001	EP0655921B1 Novel glucan preparation
12/12/2001	EP0589964B1 Method and composition to reduce myocardial reperfusion injury
12/12/2001	EP0503035B1 Novel 1alpha-hydroxy vitamin d4 and novel intermediates and analogues
12/12/2001	CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof
12/12/2001	CN1326508A Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
12/12/2001	CN1326486A Anionic-cationic polyion complexes comprising zwitterionic monomer component
12/12/2001	CN1326471A Polymer combining with phosphoric acid and preparation containing the same
12/12/2001	CN1326467A Expression and export of angiostation and endostatin as immunofusins
12/12/2001	CN1326462A Betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
12/12/2001	CN1326461A Meiosis regulating compounds
12/12/2001	CN1326460A B-membered azalides and their use as antibiotic agents
12/12/2001	CN1326459A Heteroaromatic inhibitors of fructose 1,6-bisphosphatase
12/12/2001	CN1326458A CRF receptor antagonists and methods relating thereto
12/12/2001	CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors
12/12/2001	CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/12/2001	CN1326455A Improved chemical process and pharmaceutical formulation
12/12/2001	CN1326453A Novel poyrimidine derivatives and process for preparation thereof
12/12/2001	CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors
12/12/2001	CN1326449A Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2, 4-thiazolidinedione
12/12/2001	CN1326445A Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
12/12/2001	CN1326443A Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
12/12/2001	CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III
12/12/2001	CN1326440A Piperdine CCR-3 receptor antagonists
12/12/2001	CN1326364A Antiviral formulations comprising propylene glycol and isopropyl alkanoic acid ester
12/12/2001	CN1326362A Model and method for angiogenesis inhibition
12/12/2001	CN1326361A Methods for detecting, preventing, and treating renal disorders by modulating, regulating and inhibiting connective tissue growth factor
12/12/2001	CN1326352A Hyaluronic acid gel, process for preparation thereof and medical materials containing the same
12/12/2001	CN1326351A Use of certain drugs for treating nerve root injury
12/12/2001	CN1326350A Fluticasone lotion having improved vasoconstrictor activity
12/12/2001	CN1326349A Antiviral combinations of lamivudine and adefovir
12/12/2001	CN1326348A Riluzole and alpha-tocopherol combination
12/12/2001	CN1326347A 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
12/12/2001	CN1326346A Anticonvulsant derivatives useful in treating post traumatic stress disorder
12/12/2001	CN1326345A Compounds for treatment of estrogen-dependent illnesses and methods for making and using same
12/12/2001	CN1326344A PUFA supplements
12/12/2001	CN1326343A Agent for lowering prolactin
12/12/2001	CN1326342A Treatment of addition and addiction-related behavior
12/12/2001	CN1326341A Dry powder for inhalation
12/12/2001	CN1326340A Pharmaceutical composition for treatment of acute disorders
12/12/2001	CN1326339A Controlled release bead, method of producing the same and multiple unit formulation comprising it
12/12/2001	CN1326338A Process for preparing oral calcium compositions
12/12/2001	CN1326337A Drug delivery device, especially for delivery of progestins and estrogens
12/12/2001	CN1326336A Low-irritation antiperspirant and deodorant compositions
12/12/2001	CN1326330A Therapeutic use of polymers
12/12/2001	CN1326322A Method for supplying bioavailable methionine to cow
12/12/2001	CN1326318A Antiparasitic formulations
12/12/2001	CN1326003A Medical cane sugar and its preparing process
12/12/2001	CN1325850A Acetyl pyrrolidone cephlosporins with basic substitutent group
12/12/2001	CN1325725A Medicine for treating coronary heart disease
12/12/2001	CN1325686A Flavonoids used as anti-rejection agent
12/12/2001	CN1325685A Mixtures separated from seeds of syzygium, preparations thereof, and uses as medicines containing them and components therefrom
12/12/2001	CN1325684A Application of aminoguanidine in preparing medicine to treat hyperosteogeny
12/12/2001	CN1076052C Nucleic acid sequences, carrier containing them, medical compositions and usage for treatment
12/12/2001	CN1076021C L-2',3'-dideoxy nucleoside analogs as antihepatitis B (HBV) and anti-HIV agents
12/12/2001	CN1076020C Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions
12/12/2001	CN1076019C Preparation of triazoles by organometallic addition to ketonts and intermediates therefor
12/12/2001	CN1076016C O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
12/12/2001	CN1075946C Process for preparing synergetic antimalarial-compound naphthoquine phosphate
12/11/2001	US6329557 Dispersing saponified extract in water to form dispersion; mixing to form aqueous phase; separating from residue, contacting with nonpolar solvent to dissolve lipid-soluble compounds; separating precipitate; washing
12/11/2001	US6329552 Malaria, schistosomiasis
12/11/2001	US6329545 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
12/11/2001	US6329542 Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
12/11/2001	US6329539 Prostagladin derivatives
12/11/2001	US6329538 Induce differentiation and inhibition of proliferation in various skin and cancer cell lines and useful for therapy of hyperproliferative skin diseases, such as, psoriasis, neoplastic diseases such as leukemia, breast cancer
12/11/2001	US6329526 Cycloalkyl substituted imidazoles
12/11/2001	US6329524 Cyclic sulfone containing retroviral protease inhibitors

1 ... 5947 5948 5949 5950 5951 5952 5953 5954 5955 5956 5957 5958 5959 5960 5961 5962 5963 5964 5965 5966 5967 ... 7860